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A B S T R A C T
In Slovenia, opportunistic screening was introduced in regular gynaecological practice in 1960. The proportion of
population screened was unknown, as well as there were no standards for quality assurance and control. Despite great
number of smears read, there were no major changes in invasive cervical cancer incidence in the period 1979 till 1993,
but in 1994 the incidence rate started to increase again to reach its peak in 1997 (23,1/100.000, 241 new cases). Based on
the experiences from the countries with effectively organised screening programmes, a decision was made in 1996 by the
Minister of Health to nominate a group of experts to prepare a proposal for organised cervical cancer screening pro-
gramme after testing the methodology in pilot study. In the pilot the central computerised information system (Screening
Registry) was gradually established to register all smears from the whole country, to identify women who do not attend
for screening to send them invitation for screening and to monitor screening activity and its quality. The aim of pilot was
also to develop guidelines for quality assurance and control of all procedures involved in cervical cancer screening and
treatment of intraepithelial lesions. In three years since the beginning of the national programme, nearly 70% of women
in the target age group were registered with at least one smear. All other results are presented in regular programme re-
ports. There is still place for further development of the programme, but the incidence of cervical cancer already started to
decline especially among younger women, who attend for screening more often than those aged over 50.
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Introduction
Cancer is one of the major public health problems as it
is the most common cause of morbidity and mortality to-
day, with more than 5.8 million new cases and more than
3.8 million of deaths each year in Europe1. It is projected
that by 2020 there will be 3,4 million of new cancer cases
and 2,1 million deaths. Much of this increase in absolute
numbers derives from the ageing of populations. It repre-
sents a significant and growing burden on public health
services today.
There is now sufficient understanding of the causes to
prevent at least one third of all cancers. Information is
also available that would permit the early detection and
effective treatment of a further one third of all cancers
worldwide. The overall goal of cancer control is to reduce
the incidence and mortality of cancer and to improve the
quality of life of cancer patients and their families. A well
conceived national cancer control programme is the most
effective instrument to bridge the gap between knowl-
edge and practice and achieve this goal. Integrated into
existing health systems and related services, this pro-
gramme ensures systematic and equitable implementa-
tion of control strategies across the continuum of preven-
tion, early detection, treatment and palliative care.
Screening for cancer consists of the identification of
preclinical disease by a relatively simple test. The objec-
tive of screening is to reduce the risk of death, i.e. mortal-
ity from cancer subjected to screening. For cervical can-
cer the screening test is aimed at detection of preinvasive
lesions. Therefore, reduction in the incidence of invasive
disease is the objective of screening for cervical cancer
and the indicator of the effect is the change of incidence
between those subjected to screening.
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Screening for cervical cancer is fundamental to the
provision of health care in Europe and, depending on
each health system, performed by general practitioners,
the gynaecologist or trained nurses. The dissemination
of the cervical smears depends both on the professional
interest and on the method of payment. The major in-
crease in use was in those settings where smears were
paid for through a public health insurance scheme.
Cervical Cancer Screening in
Slovenia till 2002
In Slovenia, opportunistic screening was introduced
in regular gynaecological practice in 1960, but in some
regions already in 1955 and 1956. A preventive gynaeco-
logical exam (smear included) has been practised since
then on a yearly basis and recommended to women by
gynaecologic community and paid by the health insur-
ance. The payment did not stimulate examinations of
more women, as only attendances have been paid regard-
less on how many women the exams have been per-
formed. Since 1998, a regular yearly gynaecological exam
with a smear (endo- and ecto-cervical) and colposcopy
has been paid from the obligatory health insurance and
supposed to be the right of every woman from 20 years of
age onwards. It was performed by gynaecologists work-
ing in primary reproductive health care, where changes
have also been happening, because of introduction of reg-
istration with personal gynaecologists and in some places
the accessibility to this service diminished.
Most of the smears were taken from young women,
while older women and women from the lower socio-eco-
nomic groups were frequently missed out altogether by
the system. These women are at higher risk, but make
less use of screening services, especially if attendance re-
quires individual initiative (inequalities in risk and use
of screening). In Slovenia it was found out that despite
the formally equal accessibility, only 30% of women per-
formed gynaecological examination yearly, less than half
once in every three years, depending on the region of res-
idence, and mostly those with better education. On the
other hand, the number of smears examined in the labo-
ratories (more than 300,000) could suffice to examine ev-
ery women aged 20–64 at least every three years.
In Slovenia there is one of the oldest Cancer Regis-
tries in Europe so we can monitor the incidence of cervi-
cal cancer since 1950. The time trend of invasive cervical
cancer is supposed to reflect the effectiveness of cervical
screening in our country. The crude incidence rate of in-
vasive cervical cancer increased from 22.5/100,000 in
1950 to 34/100,000 in 1962 and then decreased to 14/
100,000 in 1979, when the incidence was the lowest2.
Since then till 1993 there were no major changes (though
nothing had changed in gynaecological recommendati-
ons) but in 1994 the incidence rate started to increase
again. Furthermore, an increase of the invasive cancer
incidence in the younger age groups (30–39) has been ob-
served. In the period 1994–1998, the age specific inci-
dence rate in the age groups 30–34 and 35–39 was nearly
the same as in the period 1959–1963, at the start of the
opportunistic screening. In 2000, the incidence rate was
20/100.000, one of the highest in Europe3.
The descriptive epidemiologic analysis of cervical can-
cer in Slovenia revealed the inefficiency of opportunistic
screening in Slovenia, where lots of resources have been
wasted for a small effect on the female reproductive
health. Even though the baseline risk of cervical cancer
may have changed due to more liberal sexual behaviour
of generations, born after the Second World War, the ef-
fective screening programme should cope at least with a
part of this risk, resulting in better detection of precan-
cerous lesions and not leading to such an increase of in-
vasive cervical cancer.
Based on the experiences from the countries with ef-
fectively organised screening programmes4, a decision
was made in 1996 by the Ministry of Health and Health
insurance Company to start a pilot study to gradually in-
troduce organised cervical cancer screening. After initial
preparations, the pilot started in 1998 in the central re-
gion of Slovenia, covering approximately 300,000 wo-
men, i.e., one third of the whole female population of
Slovenia.
The objectives of this study were:
¿ to establish the central computerised information sys-
tem (Screening Registry) linked to the Central Popula-
tion Registry of Slovenia to register all smears and
monitor screening activity and to identify women who
do not attend for screening;
¿ to invite women aged 25–64, who supposedly had not
been screened in the previous five years, as they have
not been yet registered with a gynaecologist or did not
have a smear registered in the study period and to esti-
mate the proportion of women who attend screening as
a result of personal invitation;
¿ to develop guidelines for quality assurance and control
of all procedures involved in cervical cancer screening
and treatment of intraepithelial lesion and of cervical
cancer.
First, a uniform smear report form and skeleton of a
computer database were constructed. From the Central
Population Register, samples of women from the target
population were regularly made and invited to pre-ar-
ranged gynaecologic exams. In the period 1998–2001,
28,804 invitations were sent to the samples of women
mentioned. Personal invitations have resulted in nearly
50% participation rate in the group of women who do not
regularly attend the opportunistic screening. All smear
reports (in the electronic form) from all cytological labo-
ratories in the region were gathered. A central database
of the Screening Registry was thus created and then reg-
ularly updated. In the following years the reporting of
smears from all cytological laboratories from the whole
country was established, so since 2003 the register is cov-
ering the whole country and constant monitoring of the
coverage and quality has been established. National gui-
delines for cytopathology and for management of women
with abnormal smear have been published5–7.
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The legal basis for the programme was also estab-
lished: the contents of the database is included in the law
on health statistics8, the special regulation for cyto-
pathology laboratories then was published by the Minis-
try of Health9, and laboratories then have been reviewed
to evaluate whether they comply with these standards.
With the ministry’s recommendation on preventive ex-
aminations in primary reproductive health care where
screening policy was introduced, the national program-
me started in 200310.
Organised Cervical Cancer Screening
Programme in the Primary (Reproductive)
Health Care
In 2003, the Ministry of Health supported the intro-
duction of National Programme of Organized Cervical
Cancer Screening. It has a name ZORA after Slovenian
initials for organised cervical cancer screening program-
me. The central coordination office with the Screening
Registry is at the Ljubljana Institute of Oncology.
The programme advocates the population-wide active
cervical cancer screening based on quality-controlled pro-
cedures. The aim of this programme is to achieve that at
least 70% of the female population aged 20–64 will have a
smear taken in a the three-year interval.
Each woman between ages 20 and 64 is to be invited
to perform a preventive gynaecological examination to-
gether with Papanicolau smear once in every three years
(after two negative smears) either by her »personal« gy-
naecologist with whom she has already been registered
or from the Screening Centre in case she has not been
registered yet. Women aged 65 to 74 years are not invited
but are offered screening when they attend gynaecologist
for other reasons.
As it was decided that gynaecologists would invite
women already registered with them, the initial stage in-
cluded active involvement of gynaecologists in the pri-
mary health care, who had to review all their records and
make lists of women to be invited. Different computer
programmes in different practices hampered this but the
difficulties should be overcome in the future. The coordi-
nation of the programme is assured through regional co-
ordinators and national coordinator, nominated by the
Minister of Health.
Regardless of the ability to pay, the universal access to
ZORA programme is assured by including the ZORA ex-
penditure into the Slovenia’s compulsory Health Insur-
ance Fund. Thus, the organized cervical cancer screening
programme is based on all fundamental principles of eq-
uity, solidarity and participation.
The results show that in some regions the goal of 70%
of women having a smear in the last three years, has al-
ready been achieved and preliminary data from the Can-
cer Registry do not show an upward trend of cervical can-
cer any more. The invitations resulted also in greater
percentage of women being registered with their gynae-
cologists, which is currently about 80% in the target age
group. Annual reviews on the cervical cancer screening
programme ZORA is published regularly and available
on the programme’s web site also (http://www.onko-i.si/
zora/)11.
Conclusions
Systematic screening is a public health intervention
often performed in primary health care. For its sus-
tainability it should receive political support and sup-
porting legislation. An advantage is the funding system
for public health services separate and independent from
the cure and care budget, but adequate resources are
needed for management of women with abnormal sme-
ars. But in any case the health insurance systems should
incorporate funds for screening that is evidence based as
this means lower costs for treatment of advanced dis-
ease. The key for success of such a programme is organi-
sation, existence of national standards for quality assur-
ance and control and constant monitoring of short- and
long-term indicators.
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PROBIR RAKA VRATA MATERNICE – SLOVENSKO ISKUSTVO
S A @ E T A K
Oportunisti~ki probir je uveden 1960. g. u ginekolo{ku praksu u Sloveniji. Udio testirane populacije je bio nepoznat,
a nije bilo niti standarda za osiguranje kvalitete i kontrole. Unato~ velikom broju testiranih obrisaka vrata maternice
nije bilo ve}ih promjena u pojavnosti invazivnog raka vrata maternice u periodu od 1979. do 1993. g., no od 1994. g.
stopa pojavnosti je po~ela ponovo rasti kako bi dosegla vrhunac u 1997. g. (23,1/100.000, 241 novi slu~aj). Zahvaljuju}i
iskustvu zemalja s u~inkovito organiziranim programima probira, 1996. g. Ministarstvo zdravstva je donijelo odluku o
imenovanju skupine stru~njaka koja }e pripremiti prijedlog organiziranog programa probira raka vrata maternice na-
kon testiranja metoda u sklopu pilot-studije. U pilot-studiji je uspostavljen sredi{nji kompjuterski informati~ki sistem
(Registar za probir) koji prikuplja podatke o uzorcima iz cijele zemlje, identificira `ene koje nisu pristupile probiru, {alje
im poziv za testiranje te bilje`i aktivnost i kvalitetu probira. Cilj pilot-studije je tako|er bio razvoj vodi~a za osiguranje
kvalitete te kontrola svih procedura uklju~enih u probir raka vrata maternice i lije~enje intraepitelnih lezija. U tri
godine provo|enja nacionalnog programa gotovo 70% `ena ciljane dobne skupine je pristupilo probiru barem jednom.
Ostali rezultati su predo~eni u klasi~nim izvje{}ima o programu. Me|utim, jo{ uvijek ima mjesta budu}em razvoju
programa, iako je stopa pojavnosti raka vrata maternice po~ela padati, pogotovo me|u mla|im `enama, koje dolaze na
probir mnogo ~e{}e nego one u dobi iznad 50 godina.
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